Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus

Amgen (AMGN) reported third-quarter 2024 adjusted earnings of $5.58 per share, which beat the Zacks Consensus Estimate of$5.11. Earnings rose 13% year over year as higher revenues offset the impact of higher operating costs and interest expenses.Total revenues of $8.51 billion came in line with the Zacks Consensus Estimate. Total revenues rose 23$8.15 billion. Higher volumes were partially offset by lower selling prices of s ...